| Literature DB >> 19278394 |
Kevin P High1, Suzanne F Bradley, Stefan Gravenstein, David R Mehr, Vincent J Quagliarello, Chesley Richards, Thomas T Yoshikawa.
Abstract
Residents of long-term care facilities (LTCFs) are at great risk for infection. Most residents are older and have multiple comorbidities that complicate recognition of infection; for example, typically defined fever is absent in more than one-half of LTCF residents with serious infection. Furthermore, LTCFs often do not have the on-site equipment or personnel to evaluate suspected infection in the fashion typically performed in acute care hospitals. In recognition of the differences between LTCFs and hospitals with regard to hosts and resources present, the Infectious Diseases Society of America first provided guidelines for evaluation of fever and infection in LTCF residents in 2000. The guideline presented here represents the second edition, updated by data generated over the intervening 8 years. It focuses on the typical elderly person institutionalized with multiple chronic comorbidities and functional disabilities (e.g., a nursing home resident). Specific topic reviews and recommendations are provided with regard to what resources are typically available to evaluate suspected infection, what symptoms and signs suggest infection in a resident of an LTCF, who should initially evaluate the resident with suspected infection, what clinical evaluation should be performed, how LTCF staff can effectively communicate about possible infection with clinicians, and what laboratory tests should be ordered. Finally, a general outline of how a suspected outbreak of a specific infectious disease should be investigated in an LTCF is provided.Entities:
Mesh:
Year: 2009 PMID: 19278394 PMCID: PMC7166905 DOI: 10.1111/j.1532-5415.2009.02175.x
Source DB: PubMed Journal: J Am Geriatr Soc ISSN: 0002-8614 Impact factor: 5.562
Infectious Diseases Society of America–U.S. Public Health Service Grading System for Ranking Recommendations in Clinical Guidelines
| Category, Grade | Definition |
|---|---|
| Strength of recommendation | |
| A | Good evidence to support a recommendation for use |
| B | Moderate evidence to support a recommendation for use |
| C | Poor evidence to support a recommendation |
| Quality of evidence | |
| I | Evidence from ≥1 properly randomized, controlled trial |
| II | Evidence from ≥1 well‐designed clinical trial, without randomization; from cohort or case‐controlled analytical studies (preferably from >1 center); from multiple time‐series; or from dramatic results from uncontrolled experiments |
| III | Evidence from opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees |
NOTE. Adapted from Canadian Task Force on the Periodic Health Examination.